Cellular Health Screening Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 

Cellular Health Screening Market Growth & Trends

The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market. In addition, the rising adoption of the direct-to-consumer approach, the growing importance of healthy life expectancy (HALE), increasing telomere performance programs for leading a healthy life, and rising government focus on preventive healthcare are expected to drive the market.

An increasing number of individuals undergoing cellular health screening testing, such as telomere tests, to learn about the biomarkers of cell aging is also anticipated to supplement the market growth. It has been demonstrated that tests that provide information on telomere length and activity can also provide information on lifestyle and stress factors. Numerous studies have demonstrated that both acute stress and chronic stress accelerate cell aging. Thus, these tests play an important role in understanding one’s health.

Additionally, researchers can gain insights into cellular qualities by studying how physical exercise, sleep, mental health issues, alcohol use, and smoking habits alter cellular aging in various ways. The utilization of telomere tests offers insights into metabolic and genetic illnesses, enabling clinicians to make an early diagnosis and quickly and individually tailor a patient's treatment regimen. Consequently, growing interest in cellular screening and expanding research have increased kit and test demand, facilitating market growth in recent years.

The necessity for cellular screening research has grown as a result of its many applications in preventive medicine and the capacity to comprehend relationships between telomere length and aging. Bio-cell-based screenings are frequently advised throughout time, allowing patients to compare results and comprehend what modifications need to be made. Monitoring these alterations in cellular health between screenings enables quick adjustments to be made in terms of health protocols and a general improvement in illness management.

Furthermore, disorders related to aging are linked to the buildup of old, dysfunctional cells. As shown in several animal trials, research has recently established that these can be reversed by employing a variety of cellular health procedures. Consequently, it is anticipated that ongoing research and development activities in the disciplines of protein expression, proteomics, and genomics are anticipated to further boost the demand for cellular health screening products in the near future.

Request a free sample copy or view report summary: Cellular Health Screening Market Report

Cellular Health Screening Market Report Highlights

• By test type, single test panels held the largest share in 2021. This is attributed to high specificity, easy customization, and increasing product availability in the market
• In the single test panels segment, the oxidative stress tests captured the largest share in 2021. These tests aid in cancer, respiratory diseases, diabetes, cardiovascular diseases, and other diseases
• Based on sample type, the blood sample segment accounted for the largest share in 2021. The growing incidence of infectious diseases, emergence of newer pathogens, increasing demand for donated blood, and rising number of blood donations have contributed to the rising demand for blood samples for cellular health screening
• By collection site, hospitals captured the largest revenue share in 2021. A major part of the general population relies on these long-term facilities for diagnosis, treatment, and management of diseases, thus driving the segment
• North America accounted for the largest market share in 2021. An increase in the importance of Healthy Life Expectancy (HALE) and increasing number of government initiatives focused on preventive healthcare are some of the key factors expected to boost the market growth in the region
• Asia Pacific is expected to witness the fastest growth throughout the forecast period. Improving adoption and awareness of telomere performance programs and growing awareness of healthy life expectancy have contributed to regional growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cellular-health-screening-market

Cellular Health Screening Market Segmentation 

Grand View Research has segmented the global cellular health screening market based on test type, sample type, collection site, and region:

Cellular Health Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single Test Panels
  • Telomere Tests
  • Oxidative Stress Tests
  • Inflammation Tests
  • Heavy Metals Tests
• Multi-test Panels

Cellular Health Screening Sample Type Outlook (Revenue, USD Million, 2018 - 2030)

• Blood
• Saliva
• Serum
• Urine

Cellular Health Screening Collection Site Outlook (Revenue, USD Million, 2018 - 2030)

• Home
• Office
• Hospital
• Diagnostic Labs

Cellular Health Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Cellular Health Screening Market

• Telomere Diagnostics
• SpectraCell Laboratories
• Life Length
• Repeat Diagnostics, Inc.
• Cell Science Systems Corp.
• Quest Diagnostics
• LabCorp Holdings
• OPKO
• Genova Diagnostics
• Immundiagnostik AG
• DNA Labs

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Finance Lease Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 Finance Lease Market Growth & Trends

The global finance lease market size is expected to reach USD 324.40 billion by 2030, growing at a CAGR of 5.1% from 2022 to 2030, according to a new study conducted by Grand View Research, Inc. The market is anticipated to be driven by several advantages offered by finance leasing over traditional borrowing methods, including higher margins, tax advantages, and inflation-friendly and secure investments. Furthermore, the massive demand for new commercial models and branded equipment across the globe has become one of the significant factors driving the growth.

Benefits offered by leasing finance company services to lessees such as temporary occupant of the property, cost-effective method of acquiring assets, and others drive the market growth. Furthermore, it helps to free up working capital enabling the lessee to spend on its core tasks. On the other hand, the lessor, the legal owner of the asset or property, can recoup the cost of the asset and earn interest on the rental payments by the lessee.

The finance lease accounting assists businesses with capital constraints in obtaining highly-priced assets. The finance lease market still faces a few market constraints, such as the risks associated with exchange rate fluctuations. Furthermore, the difficulties encountered due to varying regulatory scenarios in different countries may also prevent finance lease service providers from offering global finance lease services.

The global COVID-19 pandemic has been favorable to market growth. Finance leasing has allowed SMEs and other businesses to grow significantly with the assistance of leasing options. Furthermore, the growing tendency of companies to finance equipment and software, aided by the Federal Reserve's interest rate reductions, is expected to create new growth opportunities for the finance leasing industry during the forecast period.

Request a free sample copy or view report summary: Finance Lease Market Report

Finance Lease Market Report Highlights

• The international business segment is expected to witness significant growth during the forecast period. The need for businesses to reduce cost and capital requirements for equipment and the ability to adapt to rapidly changing technological advancements is driving the segment growth
• The non-bank segment is expected to witness significant growth during the forecast period. Greater flexibility on interest rates and quick approvals of financing solutions offered by such institutions are driving their demand among start-ups and small businesses
• The IT & telecom segment dominated the market in 2021. Telecom and media companies are constantly aiming to grow their infrastructure to match the ever-changing market demands, which is anticipated to drive the growth of the segment
• The Asia Pacific is expected to register rapid growth during the forecast period. The rising popularity and awareness of finance leasing options across the region are expected to drive the development of the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-finance-lease-market

Finance Lease Market Segmentation

Grand View Research has segmented the global finance lease market based on product, type, application, and region:

Finance Lease Product Outlook (Revenue, USD Billion, 2017 - 2030)

• International Business
• Domestic Business

Finance Lease Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Banks
• Non-banks

Finance Lease Application Outlook (Revenue, USD Billion, 2017 - 2030)

• Transportation
• Medical Devices
• Energy & Environment
• Construction Equipment
• Industrial Machinery
• IT & Telecom
• Others

Finance Lease Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)

List of Key Players in the Finance Lease Market

• Sumitomo Mitsui Finance and Leasing Co., Ltd.
• BNP Paribas Leasing Solutions
• HSBC Group
• Wells Fargo Bank N.A.
• Texas Capital Bancshares, Inc.
• Commerce Bancshares, Inc.
• Fifth Third Bank
• Bank of America Corporation
• Crest Capital
• North Star Leasing

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sustained Release Excipients Market is Expected to Enhance USD 2.4 Billion Revenue By 2030: Grand View Research Inc.

 Sustained Release Excipients Market Growth & Trends

The global sustained release excipients market size is expected to reach USD 2.4 billion by 2030, registering a CAGR of 8.22% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of patent expirations, need for pediatric & geriatric dosage forms, and added benefits provided by sustained release formulations are factors that are positively contributing to the market potential. Sustained release formulations significantly reduce dosage frequency and improve patient compliance. These factors are further aiding industry growth. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits.

Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained release formulations, enabling higher patient compliance and improved therapeutic effect.

Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.

The use of controlled release formulations has been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice of formulations among physicians, which increases their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may have a more substantial impact on the oral solid dosage form drug manufacturing.

This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for growth of the industry in Europe, which includes France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, the presence of sophisticated healthcare infrastructure, and a rise in the number of product approvals are the factors expected to create growth opportunities in the Europe region.

Sustained release formulations are designed specifically in ways to reduce the dosage frequency. Thus, these formulations have high Active Pharmaceutical Ingredient (API) doses, which facilitate the maintenance of desired therapeutic levels. However, drug toxicity resulting from sustained release formulations is difficult to treat due to excess API. Drug retrieval in these cases becomes difficult as drugs are designed to deliver predetermined amounts at frequent time intervals. These are very rarely seen in sustained release formulations, which may hinder industry growth to a certain extent.

Request a free sample copy or view report summary: Sustained Release Excipients Market Report

Sustained Release Excipients Market Report Highlights

• The polymers product segment accounted for the largest share in 2021. Varied usage of polymers in sustained release formulations is anticipated to fuel industry growth
• Conventional use of the oral route of delivery has contributed to the segment's growth. Convenience, in terms of storage, premeasured doses, portability, and noninvasive nature of this route are some of the major factors accelerating its adoption
• The rising adoption of transdermal patches has contributed to the growth of the segment
• Targeted drug delivery constituted the largest revenue share in 2021, as a large number of industry players have strong product portfolios. Implantable sustained release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
• Europe dominated the global industry in 2021 due to the high investments in R&D and availability of highly sophisticated technologies in the region
• Asia Pacific will register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sustained-release-excipients-market

Sustained Release Excipients Market Segmentation

Grand View Research has segmented the global sustained release excipients market based on product, route of administration, technology, and region:

Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)

• Gelatin
• Polymers
• Minerals
• Sugars
• Alcohol
• Chitosan

Sustained Release Excipients Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Vaginal
• Ophthalmic
• Intravenous
• Other Route of Administrations

Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Targeted Delivery
• Micro Encapsulation
• Wurster Technique
• Transdermal
• Implants
• Coacervation
• Others

Sustained Release Excipients Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Sustained Release Excipients Market

• BASF
• International Flavors & Fragrances, Inc.
• Ashland Global
• Evonik Industries
• Croda International Plc
• Gattefossé
• Merck KGaA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market For Genetic Toxicology Testing to Witness Tremendous Growth and Expansion by 2030

 Genetic Toxicology Testing Market Growth & Trends

The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry.

Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon’s location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

Request a free sample copy or view report summary: Genetic Toxicology Testing Market Report

Genetic Toxicology Testing Market Report Highlights

• By type, the in vitro is expected to be the fastest growing segment with the largest share of the Genetic Toxicology Testing Market in 2021. Owing to the rising requirement by regulatory agencies for genotoxicity in the food industry
• By application, the pharmaceutical & biotechnology segment is estimated to become a major market contributor. This is attributed to an increase in the development of cell and gene therapy, coupled with increasing use of pharmacogenomics and personalized medicines
• The Asia Pacific region is projected to grow substantially over the forecasted period owing to the increasing imports of novel food and tightening test regulations for the same, especially in Australia
• By product, the service segment captured a significant proportion of the share in 2021, owing to the increasing demand by pharmaceutical and biotechnology companies for nonclinical works. Also, increasing strategic initiatives by contract research organizations is a major growth determinant
• North America was a major regional market for genetic toxicology in 2021 owing to the availability of efficient players in the region to match the demand by pharma and biotech companies. The increasing R&D in personalized medicines is also a significant factor
• Some of the main market players include Thermo Fisher Scientific, Inc.; Charles River Laboratories International; Laboratory Corp of America Holdings; and Eurofins Scientific

Access Press Release@ https://www.grandviewresearch.com/press-release/global-genetic-toxicology-testing-market

Genetic Toxicology Testing Market Segmentation

Grand View Research has segmented the global genetic toxicology testing market based on type, product, application, and region:

Genetic Toxicology Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• In Vitro
• In Vivo

Genetic Toxicology Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Consumables
• Assays
• Services

Genetic Toxicology Testing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology
• Food Industry
• Cosmetics Industry
• Other

Genetic Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Genetic Toxicology Testing Market

• Thermo Fisher Scientific, Inc.
• Charles River Laboratories International
• Laboratory Corp of America Holdings
• Eurofins Scientific
• Jubilant Life Sciences Limited
• Syngene International Limited
• Gentronix Ltd.
• Inotiv Inc.
• Creative Bioarray
• MB Research Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Structural Adhesive Market Advanced Technologies and Growth Opportunities Worldwide By 2030

 Structural Adhesive Market Growth & Trends

The global structural adhesive market size is expected to reach USD 31.9 billion by 2030, as per the new report by Grand View Research, Inc., registering a CAGR of 5.8% from 2022 to 2030. The demand for the product is attributed to the rise in the consumption of the product in the construction, transportation, and consumer appliances industries. Additionally, it is utilized in creating a bond between metals, plastics, foams, and fabrics in furniture.

Adhesives are extensively used in the majority of day-to-day products. The furniture industry uses several types of adhesives such as polyvinyl acetate, synthetic rubber-based adhesive, cyanoacrylates, chloroprene rubber, and epoxy. Factors such as growing demand for hybrid and durable rubber and rising inclination toward modular and compact furniture are anticipated to drive the furniture industry, leading to the growth of the market during the forecast period.

Several advantages of adhesives such as high flexibility, lightness, chemical, corrosion & dust resistance, and compatibility with varied substances are anticipated to drive the demand for the product from the construction industry in HVAC, roofing, cables, floorings, windows, carpet, and others.

The market growth was negatively impacted for a short period due to COVID-19 owing to the shutting down of manufacturing plants in the automotive, industrial, and construction sectors. The demand fluctuations from these end-use industries had a direct impact on structural adhesives. Additionally, the lockdown impacted the industrial construction sector owing to the slowdown in construction activities.

Companies are continuously involved in the expansion of manufacturing plants in order to ensure a quick supply of their products to customers and enhance the production capacity of the product. For instance, Henkel AG & Co., AGaA opened its new manufacturing plant in Mexico to ensure the timely availability of the products to the customers.

Request a free sample copy or view report summary: Structural Adhesive Market Report

Structural Adhesive Market Report Highlights

• The water-based technology segment is expected to expand at a lucrative CAGR of 6.0% during the forecast period based on revenue owing to an increase in its bonding applications in leather, wood, and textiles
• The epoxy product segment is expected to expand at a significant CAGR of 6.2% from 2022 to 2030 based on revenue as it ensures high strength towards permanent bonding applications
• The construction application segment is anticipated to register a revenue-based CAGR of 5.8% during the forecast period due to the rise in the consumption of the product in residential and commercial construction activities
• Asia Pacific region is anticipated to register the fastest CAGR of 6.3% during the forecast period based on revenue owing to a rise in the industrial output in China, India, and Southeast Asia
• The growth of the North American construction industry is largely supported by the rapid expansion of the residential housing sector. The construction sector in the U.S. has outperformed Mexico and Canada in the past few years
• Companies have been boosting their production capacities in order to keep up with the rising demand from the end-use industries such as construction and transportation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-structural-adhesives-market

Structural Adhesive Market Segmentation

Grand View Research has segmented the global structural adhesive market based on product, technology, application, and region:

Structural Adhesive Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Urethanes
• Epoxy
• Acrylic
• Cyanoacrylic
• Others

Structural Adhesive Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Water-based
• Solvent-based
• Others

Structural Adhesive Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Transportation
• Construction
• Consumer Appliances
• Furniture
• Others

Structural Adhesive Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Korea
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of the Structural Adhesive Market

• Henkel AG & Co. KGaA
• Dow
• 3M
• B. Fuller Company
• Franklin International
• AVERY DENNISON CORPORATION
• Ashland
• Lord Corporation (Parker Hannifin Corp.)
• Arkema
• Hubei Huitian Adhesive Enterprise Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monkeypox Vaccine And Treatment Market to Reflect a Holistic Expansion During 2022 to 2030: Grand View Research Inc.

 Monkeypox Vaccine And Treatment Market Growth & Trends

The global monkeypox vaccine and treatment market size is expected to reach USD 184.79 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.16% from 2022 to 2030. The growing government initiatives for combating the monkeypox virus threat and a surge in awareness about the disease are the major factors driving the market. Moreover, an increase in R&D activities to develop vaccines and treatments is expected to fuel market growth.

The incidence rate of infection is higher in men as compared to women. According to the CDC’s data of August 2021, the monkeypox virus affected over 2,231 men of age 31 to 35 as compared to 11 women of age 31 to 35. The infection rate of the virus is more common in people between 20 to 50 years of age. Thus, the rising infection rates from the monkeypox virus are anticipated to fuel the demand for novel and effective treatment.

The increasing funding for boosting research activities and expanding manufacturing capacities of vaccine plants is likely to fuel market demand. For instance, in August 2022, the U.S. Department of Health and Human Services announced a funding of USD 11 million for providing support to fill and finish the manufacturing of JYNNEOS vaccine approved for preventing monkeypox and smallpox at GRAM, Michigan. This funding will assist GRAM to purchase extra equipment for JYNNEOS production.

Moreover, in July 2022, the pandemic institute awarded funding of around USD 580,049 to Liverpool researchers for managing the global threat of monkeypox. The funding is awarded for promoting research activities for understanding the stigma around the disease and developing new treatment regimens.

Furthermore, various strategic initiatives undertaken by the leading market players to strengthen their portfolio and market footprint are expected to facilitate market expansion. For instance, in August 2022, Bavarian Nordic A/S announced an agreement with Pan American Health Organization to boost equitable access to the Bavarian Nordic A/S monkeypox vaccine for countries in the Caribbean and Latin America. The vaccine delivery is likely to commence in the month of September.

In addition, in May 2022, SIGA Technologies, Inc. announced that its IV formulation TPOXX (tecovirimat) received U.S. FDA approval for the treatment of smallpox. The intravenous formulation is an alternative for patients who cannot swallow the oral formulation of the TPOXX. The IV formulation of TPOXX is also being used to manage the symptoms of monkeypox in the U.S.

However, the chances of side effects from the vaccine may hinder the market growth in the coming years. Some of the common side effects associated with the monkeypox vaccine include induration, muscle pain, swelling, nausea, and itching, among others.

Request a free sample copy or view report summary: Monkeypox Vaccine And Treatment Market Report

Monkeypox Vaccine And Treatment Market Report Highlights

• Based on product, the drugs segment held the largest share in 2022 owing to ongoing product approvals and increasing demand for antiviral drugs for the treatment
• The male segment accounted for the largest share in 2022 due to the higher prevalence of infections among men
• By route of administration, the oral segment dominated the market in 2022 due to the increased demand for oral antiviral drugs for the treatment of monkeypox disease
• The hospitals segment was the largest segment in 2022. The specialty clinics segment is anticipated to register the fastest growth rate throughout the forecast period
• Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increased risk of monkeypox infections and increasing awareness about vaccination

Access Press Release@ https://www.grandviewresearch.com/press-release/global-monkeypox-vaccine-treatment-market

Monkeypox Vaccine And Treatment Market Segmentation

Grand View Research has segmented the global monkeypox vaccine and treatment market based on product, gender, route of administration, end-use, and region:

Monkeypox Vaccine And Treatment Product Outlook (Revenue, USD Million, 2022 - 2030)

• Vaccine
  • JYNNEOS/Imvanex
  • Smallpox Vaccine
  • Others
• Drugs
  • Tecovirimat
  • Brincidofovir
  • Cidofovir
  • Others
• Vaccinia Immune Globulin (VIG)

Monkeypox Vaccine And Treatment Gender Outlook (Revenue, USD Million, 2022 - 2030)

• Male
• Female
• Others

Monkeypox Vaccine And Treatment Route of Administration Outlook (Revenue, USD Million, 2022 - 2030)

• Oral
• Injectable

Monkeypox Vaccine And Treatment End-use Outlook (Revenue, USD Million, 2022 - 2030)

• Hospitals
• Specialty Clinics
• Others

Monkeypox Vaccine And Treatment Regional Outlook (Revenue, USD Million, 2022 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Monkeypox Vaccine And Treatment Market

• Bavarian Nordic
• SIGA Technologies
• Chimerix
• EMERGENT
• Gilead Sciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ingestible Sensors Market Size, Industry Share And Growth Analysis For 2023-2030: Grand View Research Inc.

 Ingestible Sensors Market Growth & Trends

The global ingestible sensors market size is expected to reach USD 1.8 billion by 2030, registering a CAGR of 10.90% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing need for medical adherence and real-time monitoring of health along with the rising prevalence of chronic diseases are some of the factors driving the market growth. Furthermore, improvement in patient compliance to treatment is boosting the usage of ingestible sensors.

Increasing research on using smart pills for the detection of gut diseases, cancer, and others.is likely to favor market growth. In July 2020, a team of researchers at the University of Saskatchewan received USD 250,000 from the federal New Frontiers in Research Fund for research on an AI-enabled capsule intended for the early diagnosis of gastrointestinal cancers. Smart-Cap consists of wireless biosensors that can analyze targeted cancer biomarkers and locate tumors and bleeding, resulting in greater accuracy.

Rising cases of chronic diseases, such as diabetes, hypertension, and cancer have also led to market expansion. According to the International Diabetes Federation (IDF), around 783 million people across the world are projected to have diabetes by 2045. In addition; the growing geriatric population is also leading to numerous health issues, which is further rising the incidences of such chronic diseases.

With technological advancements, ingestible sensors are growing rapidly in the field of digital medicine. Thus, they are anticipated to grow further in the applications like customized drug delivery. However, costly raw materials and techniques for the development and design of this product may impede market growth.

COVID-19 has had a negative impact on the ingestible sensors market owing to transportation restrictions, delays in raw material procurement, and a decline in endoscopy procedures. The situation is now stabilizing as key players are adopting new strategies to drive market growth. For instance, in September 2020, CapsoVision Inc. announced that the US FDA will apply enforcement discretion to allow patients, who are determined to be eligible for at-home administration of the CapsoCam Plus small bowel capsule endoscope, during the COVID-19.

Request a free sample copy or view the report summary: Ingestible Sensors Market Report

Ingestible Sensors Market Report Highlights

• In 2022, the temperature sensorssegment led the market owing to their benefits in diagnosing and treating heat-related illnesses, particularly among athletes
• The imagesensors segment is projected to show significant growth during the forecast period due to their accuracy and clear images for the diagnosis of critical diseases
• Based on component, sensors held the largest revenue share in 2022, owing to the advanced and expensive technology used in these devices and increasing research to use them for the diseases diagnosis
• The medical segment accounted for the largest revenue share in 2022 owing to the high use of edible sensors in drug delivery and patient monitoring plus the rising prevalence of chronic diseases
• North America held the largest revenue share in 2022 due to the greater acceptance of advanced technologies
• Asia Pacific is anticipated to register a significant CAGR during the forecast period on account of the increasing geriatric population and prevalence of chronic diseases, especially in the developing countries
• Key players are contributing to the growth of the market through research, collaboration, and partnerships. For instance, in January 2021, etectRx partnered with Pear Therapeutics for the development of two products that will combine etectRx’s ingestible sensors with Pear’s digital therapeutics

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ingestible-sensors-market

Ingestible Sensors Market Segmentation

Grand View Research has segmented the global ingestible sensors market based on the component, sensor type, vertical, and region:

Ingestible Sensors Component Outlook (Revenue, USD Million, 2017 - 2030)

• Sensors
• Wearable Patch/Data Recorder
• Software

Ingestible Sensors Sensor Type Outlook (Revenue, USD Million, 2017 - 2030)

• Temperature Sensor
• Pressure Sensor
• pH Sensor
• Image Sensor

Ingestible Sensors Vertical Outlook (Revenue, USD Million, 2017 - 2030)

• Medical
• Sports And Fitness
• Others

Ingestible Sensors Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Ingestible Sensors Market include

• Olympus Corporation
• Otsuka Holdings Co., Ltd.
• Medtronic
• etectRx
• CapsoVision, Inc.
• Q., Inc.
• IntroMedic
• JINSHAN Science & Technology
• Check-Cap

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiology Information Systems Market Trends Regulations And Competitive Landscape Outlook to 2030

 Radiology Information Systems Market Growth & Trends

The global radiology information systems market size is expected to reach USD 1.9 billion by 2030, registering a CAGR of 10.19% from 2023 to 2030, according to a new report by Grand View Research, Inc. This market growth is driven by the factors such as the increasing incidences of chronic diseases and the adoption of advanced technologies in healthcare facilities. The growing usage of digital healthcare infrastructure, which helps collect and manage information generated by hospitals, clinics, and institutes, has enhanced the efficiency and effectiveness of their services.

The integration of Artificial Intelligence (AI) into radiology information system (RIS) offers lucrative growth opportunities for the market. This will result in smoother workflows, better patient care, and consistent support for radiologists. It also helps radiologists to deliver a coordinated ecosystem experience to make faster, more accurate, and more consistent diagnoses. Additionally, government initiatives to increase the adoption of RIS are expected to boost market growth.

An increasing number of medical imaging tests for various diseases is anticipated to drive the growth of the market. As per Harvard Health, around 80 million CT scans were performed in the U.S. annually. Furthermore, the number of radiology labs and increasing installations of MRI and CT scans have created the demand for RIS in hospitals.

COVID-19 slowed the growth of the market. This was mainly due to the decline in the number of non-urgent medical imaging procedures during the first wave. However, patient volumes recovered strongly in the second half. Many government organizations recommended radio-imaging tests for the detection of black fungus among COVID-19 patients. This positively impacted growth of the market in 2021.

Request a free sample copy or view the report summary: Radiology Information Systems Market Report

Radiology Information Systems Market Report Highlights

• Based on deployment mode, the web-based segment held the largest revenue share in 2022, due to workflow enhancement features such as scheduling, document imaging, automated insurance eligibility functions, and billing
• Based on product, the integrated RIS segment accounted for the largest market share in the year 2022. It offers data analysis with the help of Picture Archiving and Communication System (PACS) for the development of IT service models
• Hospitals, emergency healthcare service providers, and physicians are a few RIS end-users. Hospitals majorly prefer radiology solutions for patient scheduling, and appointments, along with tracking patient history and records
• North America led the radiology information systems market in 2022 in terms of revenue attributed to the technological advancements and presence of major market players
• In July 2021, Kestral, an Australia RIS company, Aceso Health, a healthcare solution provider in New Zealand, and Sorsix Technologies entered into a multi-year collaboration. Under the terms of the agreement, the companies will combine Aceso's Snap scan Patient Online Booking System with Kestral's Karisma RIS.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-radiology-information-system-ris-market

Radiology Information Systems Market Segmentation

Grand View Research has segmented the global radiology information systems market based on the deployment mode, product, and end-use.

RIS Deployment Mode Outlook (Revenue, USD Million, 2016 - 2030)

• Web-based
• On-premise
• Cloud-based

RIS Product Outlook (Revenue, USD Million, 2016 - 2030)

• Integrated RIS
• Standalone RIS

RIS End-Use Outlook (Revenue, USD Million, 2016 - 2030)

• Hospitals & Clinics
• Outpatient Department (OPD)
• Others

RIS Regional Outlook (Revenue, USD Billion, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in Radiology Information Systems (RIS) Market

• Oracle
• General Electric Company
• IBM
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• All scripts Healthcare, LLC
• Epic Systems Corporation
• McKesson Corporation
• MedInformatix, Inc.
• eRAD
• Pro Medicus, Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Corporate Wellness Market Witness Excellent Revenue Growth During 2023-2030: Grand View Research Inc

 Corporate Wellness Market Growth & Trends

The global corporate wellness market size is expected to reach USD 74.9 billion by 2030, expanding at a CAGR of 4.47% during the forecast period, based on a new report by Grand View Research, Inc. Rising obese and overweight population increases insurance costs that account for the financial burden on employers. Corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, poor eating, and lack of exercise.

The pandemic has caused a change in the process of delivering wellness services. Although in-person sessions have resumed to some extent, the virtual platform has been made available to at-risk employees to meet their psychological and fitness needs. Initially, the lockdown imposed due to COVID-19 resulted in a transition to work from home, causing a great deal of stress. Companies around the globe are modifying their corporate wellness strategies to meet the emerging public health crisis due to COVID-19.

Organizations are increasingly using corporate wellness programmes to boost employee health and productivity, mitigate health risks, and minimize employee healthcare expenses. Businesses are more conscious of the importance of maintaining a psychologically and physically healthy workforce. As a result, capital investment in employee wellness programmes, solutions, and services has surged. Absenteeism expenses are reduced by USD 2.7 for every dollar spent on fitness programmes, according to a study conducted by Harvard economists. As a direct consequence, employees must be encouraged to live a healthier lifestyle in order to perform better.

Employers providing the programs have noticed a significant rise in productivity and a decline in leaves and attrition. In addition, companies in the U.K. initiated the Fit for Work service, which offers a tax benefit of USD 663.3 per year. Organizations are providing wearables, such as Fitbit, Apple, and Google watches, which helps in keeping track of parameters such as heart rate and blood pressure.

Moreover, the International Labor Organization (ILO) estimates that the Asia-Pacific employs 1.9 billion people. Globalization has led in significant economic expansion throughout the region, with most countries experiencing a continuous increase in the number of employees. Additionally, the region's workforce is aging, with the region's population aged 60 and over predicted to grow by 24% by 2050, according to the United Nations report. This would result in an increase in the burden of chronic diseases among the region's working population in the following years. These factors create a potential for the market to grow in emerging countries throughout the forecast period.

Request a free sample copy or view report summary: Corporate Wellness Market Report

Corporate Wellness Market Report Highlights

• In terms of service, the health risk assessment segment dominated the corporate wellness market in 2022. The health assessment activities enable employers to implement strategic initiatives to deal with the identified health risks
• The stress management segment is likely to showcase the fastest growth rate from 2023 to 2030, owing to the rising preference for on-site yoga and meditation services and the rising prevalence of depression and anxiety due to the COVID-19 pandemic.
• Based on End-Use, large scale organizations segment dominated the market in 2022. The infrastructure in large scale companies makes conducting fitness services easier and convenient
• North America dominated the market in 2022 due to the popularity of corporate wellness in the region. According to a survey by Benefits Canada conducted on 1300 employers, North America had the highest number of corporate wellness programs. More than 80.0% of the employers in North America are offering corporate wellness services to their employees

Access Press Release@ https://www.grandviewresearch.com/press-release/global-corporate-wellness-market

Corporate Wellness Market Segmentation

Grand View Research has segmented the global corporate wellness market based on service, end-use, category, delivery model, and region:

Corporate Wellness Service Outlook (Revenue, USD Million, 2016 - 2030)

• Health Risk Assessment
• Fitness
• Smoking Cessation
• Health Screening
• Nutrition & Weight Management
• Stress Management
• Others

Corporate Wellness End-Use Outlook (Revenue, USD Million, 2016 - 2030)

• Small Scale Organizations
• Medium Scale Organizations
• Large Scale Organizations

Corporate Wellness Category Outlook (Revenue, USD Million, 2016 - 2030)

• Fitness & Nutrition Consultants
• Psychological Therapists
• Organizations/Employers

Corporate Wellness Delivery Model Outlook (Revenue, USD Million, 2016 - 2030)

• Onsite
• Offsite

Corporate Wellness Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Corporate Wellness Market

• ComPsych
• Wellness Corporate Solutions
• Virgin Pulse
• EXOS
• Marino Wellness
• Privia Health
• Vitality
• Wellsource, Inc.
• Central Corporate Wellness
• Truworth Wellness
• SOL Wellness

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.